Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of Prostate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04221542
What this trial is testing

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Amgen 479
Testing effectiveness (Phase 2)Active Not RecruitingNCT07285694
What this trial is testing

AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Arsenal Biosciences, Inc. 190
Not applicableStudy completedNCT05423431
What this trial is testing

Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009)

Who this might be right for
Prostate Cancer
BioProtect 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT02312557
What this trial is testing

Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

Who this might be right for
Castration-Resistant Prostate CarcinomaHormone-Resistant Prostate CancerPSA Progression+2 more
OHSU Knight Cancer Institute 58
Early research (Phase 1)Study completedNCT02057237
What this trial is testing

A Safety and Feasibility Study of Mitotane in Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 1
Testing effectiveness (Phase 2)Active Not RecruitingNCT05924672
What this trial is testing

Efficacy of Ra-223 in PSMA PET Optimally Selected Patients

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Malignant Neoplasm in the BoneStage IVB Prostate Cancer AJCC v8
University of California, San Francisco 2
Post-approval studies (Phase 4)UnknownNCT03202381
What this trial is testing

Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix

Who this might be right for
Prostate Cancer
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 35
Large-scale testing (Phase 3)UnknownNCT03852654
What this trial is testing

18F-DCFPyL PET-CT Scan and Prostate Cancer

Who this might be right for
Prostate Cancer Adenocarcinoma
Lida Jafari 170
Testing effectiveness (Phase 2)Study completedNCT00436956
What this trial is testing

AZD2171 to Treat Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 59
Testing effectiveness (Phase 2)UnknownNCT05076851
What this trial is testing

Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate Cancer

Who this might be right for
Neoadjuvant Therapy \High Risk Prostate Cancer
Hongqian Guo 2
Very early researchStudy completedNCT03661437
What this trial is testing

Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy

Who this might be right for
Prostate Carcinoma
City of Hope Medical Center 33
Not applicableUnknownNCT05161728
What this trial is testing

PSMA Response in Metastasized Hormone Sensitive Prostate Cancer

Who this might be right for
Prostate Cancer
Roderick van den Bergh 150
Testing effectiveness (Phase 2)Study completedNCT02326805
What this trial is testing

PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance

Who this might be right for
Stage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7
National Cancer Institute (NCI) 154
Testing effectiveness (Phase 2)Ended earlyNCT00879619
What this trial is testing

Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer+3 more
John P. Fruehauf 4
Not applicableLooking for participantsNCT07741929
What this trial is testing

Patient and Provider Perspectives on Genetic Risk Profiling

Who this might be right for
Prostate Cancer
Royal Marsden NHS Foundation Trust 40
Not applicableStudy completedNCT04034095
What this trial is testing

A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan

Who this might be right for
Prostatic Neoplasms
Janssen Pharmaceutical K.K. 979
Testing effectiveness (Phase 2)Study completedNCT00078845
What this trial is testing

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

Who this might be right for
Breast CancerLung CancerNeurotoxicity+3 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)UnknownNCT05376722
What this trial is testing

Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate Cancer

Who this might be right for
Neoadjuvant Therapy
Hongqian Guo 30
Large-scale testing (Phase 3)UnknownNCT03119857
What this trial is testing

Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14

Who this might be right for
Prostatic Neoplasms
Göteborg University 349
Not applicableEnded earlyNCT03242265
What this trial is testing

Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With Biopsy

Who this might be right for
Immunity, InnateProstatic Neoplasm
ATGen Canada Inc 84
Next Page